促胃动力药

结论（1）PG缺乏条件下促胃动力药胃复安可引起胃黏膜出血性损伤，可能与ET-1升高、NO下降致胃黏膜微循环紊乱有关。

Conclusions ( 1 ) Gastric prokinetic drugs metoclopramide may induce damage in rat stomach under PG deficient conditions . The higher ET-1 level and lower NO level may cause gastric microcirculation disturbance .

通过对患者进行宣教，给予抑酸剂、质子泵抑制或H2受体拮抗剂及促胃动力药等治疗，20例患者中6例口服药物7~14d症状缓解，21d左右症状消失；

After the education and treatment of anti-acid medicine , PPI or histamine receptor antagonist and gastro-kinetic agent , the symptoms of six cases improved within 7 ~ 14 d , disappeared after 21 d ;

抗抑郁药联合促胃动力药治疗功能性消化不良的研究·

Therapeutic Effect of Combined Treatment with Antidepressant and Gastro-kinetic Agent on Functional Dyspepsia

全部患儿予微量经口喂养或促胃动力药治疗后均治愈。

Conclusion : To treat FD in children with YWDT decoction is superior to single dynamic drug for stomach .

本文简述了引发胃动力不足的原因和产生的机理，促胃动力药的作用机理和发展。

The mechanism and reason of descent of gastrointestinal power was briefly described in this paper , and the mechanism and development of gastroprokinetic agent was also introduced .